This independent UPLC-MS lab test confirms Semaglutide 5.05mg from Direct Peptides at 99.19% purity. The analysis was conducted by Horizon Analytical on March 6, 2026. Semaglutide is a GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. A purity level of 99.19% indicates minimal contamination and high-grade synthesis. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.